Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 25.02% is in line with its 2-year average of 24.85%, around the middle of its 2-year range (22.65%–28.82%).
0.06% above its 12-month average of 25.00%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 28.82%.
GROSS MARGIN
25.02%
GROSS MARGIN AVG TTM
25.00%
GROSS MARGIN AVG 3Y
N/A
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+0.06%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
58.99%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-57.59%
vs the sector median at left
Market Cap
$26.91B
Gross Margin
33.15%
TTM Avg
32.39%
3Y Avg
33.17%
5Y Avg
35.04%
Market Cap
$26.52B
Gross Margin
59.30%
TTM Avg
57.84%
3Y Avg
57.54%
5Y Avg
57.23%
Market Cap
$26.08B
Gross Margin
27.85%
TTM Avg
27.30%
3Y Avg
28.39%
5Y Avg
31.16%
Market Cap
$28.91B
Gross Margin
42.90%
TTM Avg
40.85%
3Y Avg
40.34%
5Y Avg
40.27%
Market Cap
$25.30B
Gross Margin
36.77%
TTM Avg
35.27%
3Y Avg
37.10%
5Y Avg
37.60%
Market Cap
$24.40B
Gross Margin
92.62%
TTM Avg
92.70%
3Y Avg
93.10%
5Y Avg
93.74%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medline Inc. (MDLN) | $27.29B | 25.02% | 25.00% | N/A | N/A |
| Quest Diagnostics Incorporated (DGX)vs › | $26.91B | 33.15% | 32.39% | 33.17% | 35.04% |
| Mettler-Toledo International Inc. (MTD)vs › | $26.52B | 59.30% | 57.84% | 57.54% | 57.23% |
| Labcorp Holdings Inc. (LH)vs › | $26.08B | 27.85% | 27.30% | 28.39% | 31.16% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $28.91B | 42.90% | 40.85% | 40.34% | 40.27% |
| West Pharmaceutical Services, Inc. (WST)vs › | $25.30B | 36.77% | 35.27% | 37.10% | 37.60% |
| Incyte Corporation (INCY)vs › | $24.40B | 92.62% | 92.70% | 93.10% | 93.74% |
| BioNTech SE (BNTX)vs › | $24.16B | 70.98% | 78.98% | 81.24% | 82.89% |
| Zoetis Inc. (ZTS)vs › | $30.57B | 70.87% | 69.79% | 68.91% | 68.46% |
| Waters Corporation (WAT)vs › | $31.23B | 50.78% | 58.60% | 58.69% | 58.45% |
Gross Margin
25.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 28.82% |
| 2026-03-31 | 22.65% |
| 2025-12-31 | 24.58% |
| 2025-09-30 | 23.87% |
| 2025-06-30 | 25.11% |
| 2025-03-28 | 24.82% |
| 2024-09-30 | 24.80% |
| 2024-06-30 | 24.16% |
